Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 5, 2003, Pages 1766-1770

  Li, Jian ^a,d   Milne, Robert W ^a,b   Nation, Roger L ^a,d   Turnidge, John D ^c   Smeaton, Timothy C ^b   Coulthard, Kingsley ^c  

^a Centre for Pharmaceutical Research   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIN; COLISTIN A; COLISTIN B; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; DRUG BINDING; DRUG BLOOD LEVEL; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLISTIN; INJECTIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0038673319     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.5.1766-1770.2003     Document Type: Article

References (28)

1. Abe, M., K. Shimizu, M. Ouchi, and T. Matsumoto. 1976. Studies on sodium colistin methane sulfonate (CL-M) on metabolism in the urine and bile of rabbits. Chemotherapy 24:1592-1596.
2. Al-Khayyat, A. A., and A. L. Aronson. 1973. Pharmacologic and toxicologic studies with the polymyxins. II. Comparative pharmacologic studies of the sulfate and methanesulfonate salts of polymyxin B and colistin in dogs. Chemotherapy 19:82-97.
3. Banerjee, D., and D. Stableforth. 2000. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way? Drugs 60:1053-1064.
4. Beringer, P. 2001. The clinical use of colistin in patients with cystic fibrosis. Curr. Opin. Pulm. Med. 7:434-440.
5. Birnie, J. H., and J. Grayson. 1952. Observations on temperature distribution and liver blood flow in the rat. J. Physiol. 116:189-201.
6. Davies, B., and T. Morris. 1993. Physiological parameters in laboratory animals and humans. Pharmacol. Res. 10:1093-1095.
7. Decolin, D., P. Leroy, A. Nicolas, and P. Archimbault. 1997. Hyphenated liquid chromatographic method for the determination of colistin residues in bovine tissues. J. Chromatogr. Sci. 35:557-564.
8. Evans, M. E., D. J. Feola, and R. P. Rapp. 1999. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother. 33:960-967.
9. Hanberger, H., D. Diekema, A. Fluit, R. Jones, M. Struelens, R. Spencer, and M. Wolff. 2001. Surveillance of antibiotic resistance in European ICUs. J. Hosp. Infect. 48:161-176.
10. Hancock, R. E., and D. S. Chapple. 1999. Peptide antibiotics. Antimicrob. Agents Chemother. 43:1317-1323.
11. Koch, C., and N. Hoiby. 1993. Pathogenesis of cystic fibrosis. Lancet 341:1065-1069.
12. Koch-Weser, J., V. W. Sidel, E. B. Federman, P. Kanarek, D. C. Finer, and A. E. Eaton. 1970. Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy. Ann. Intern. Med. 72:857-868.
13. Koyama, Y., A. Kurosasa, A. Tsuchiya, and K. Takakuta. 1950. A new antibiotic 'colistin' produced by spore-forming soil bacteria. J. Antibiot. 3:457-458.
14. Levin, A. S., A. A. Barone, J. Penco, M. V. Santos, I. S. Marinho, E. A. Arruda, E. I. Manrique, and S. F. Costa. 1999. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin. Infect. Dis. 28:1008-1011.
15. Li, J., R. W. Milne, R. L. Nation, J. D. Turnidge, K. Coulthard, and D. W. Johnson. 2001. A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. J. Chromatogr. B 761:167-175.
16. a. Li, J., R. W. Milne, R. L. Nation, J. D. Turnidge, and K. Coulthard. 2003. Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography. Antimicrob. Agents Chemother. 47:1364-1370.
17. Littlewood, J. M., C. Koch, P. A. Lambert, N. Hoiby, J. S. Elborn, S. P. Conway, R. Dinwiddie, and F. Duncan-Skingle. 2000. A ten year review of colomycin. Respir. Med. 94:632-640.
18. National Nosocomial Infections Surveillance System. 1998. National Nosocomial Infections Surveillance (NNIS) System report; data summary from October 1986-April 1998. Am. J. Infect. Control 26:522-533.
19. Orwa, J. A., C. Govaerts, R. Busson, E. Roets, A. Van Schepdael, and J. Hoogmartens. 2001. Isolation and structural characterization of colistin components. J. Antibiot. 54:595-599.
20. Orwa, J. A., A. Van Gerven, E. Roets, and J. Hoogmartens. 2000. Development and validation of a liquid chromatography method for analysis of colistin sulphate. Chromatographia 51:433-436.
21. Poole, K. 2001. Multidrug resistance in Gram-negative bacteria. Curr. Opin. Microbiol. 4:500-508.
22. Reed, M. D., R. C. Stern, M. A. O'Riordan, and J. L. Blumer. 2001. The pharmacokinetics of colistin in patients with cystic fibrosis. J. Clin. Pharmacol. 41:645-654.
23. Renard, L., P. Sanders, and M. Laurentie. 1991. Pharmacokinetics of colistin sulfate administered by intravenous and intramuscular routes in the calf. Ann. Rech. Vet. 22:387-394.
24. Stern, R. C. 1996. Denmark to the rescue. Pediatr. Pulmonol. 21:151-152.
25. Troillet, N., M. H. Samore, and Y. Carmeli. 1997. Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin. Infect. Dis. 25:1094-1098.
26. Wolinsky, E., and J. D. Hines. 1962. Neurotoxic and nephrotoxic effects of colistin in patients with renal disease. N. Engl. J. Med. 266:759-768.
27. Ziv, G., J. F. Nouws, and C. A. van Ginneken. 1982. The pharmacokinetics and tissue levels of polymyxin B, colistin and gentamicin in calves. J. Vet. Pharmacol. Ther. 5:45-58.
28. Ziv, G., M. Wanner, and J. Nicolet. 1980. Clinical pharmacology of polymyxin B, colistin, and colistimethate in young dairy calves. J. Vet. Pharmacol. Ther. 3:87-94.